Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations.
JCO Precis Oncol
; 7: e2300095, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37410974
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urologic Neoplasms
/
Poly(ADP-ribose) Polymerase Inhibitors
Type of study:
Clinical_trials
Limits:
Aged
/
Aged80
/
Humans
/
Middle aged
Language:
En
Journal:
JCO Precis Oncol
Year:
2023
Document type:
Article
Country of publication:
United States